Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Effectiveness of Remimazolam Tosilate Versus Midazolam in Elderly Patients Undergoing Gastrointestinal Endoscopy: A Multicenter ,Prospective, Double-Blinded, Randomized Controlled Study

NCT04656964 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT04656964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04656964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Effectiveness of Remimazolam Tosilate Versus Midazolam in Elderly Patients Undergoing Gastrointestinal Endoscopy: A Multicenter ,Prospective, Double-Blinded, Randomized Controlled Study
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2021
Completion date
December 31, 2022
Enrollment
353 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elderly patients, gastrointestinal endoscopy, midazolam, remimazolam